Publication at Second Faculty of Medicine, Third Faculty of Medicine |
2020
Abstract
Infantile hemangioma (IH) occurs in 5 to 10% of children under one year of age. This benign vascular tumor is characterized by three phases of growth - proliferation, plateau and involution.
Modern non-selective β-blocker systemic therapy (propranolol) offers children an effective, safe and non-invasive solution. Starting the therapy in the proliferative phase is crucial for effectiveness.